What researchers published on Chronic lymphocytic leukaemia
945 papers, newest first.
Showing 120 of 945
Not labelled yetFit for the fight: BTK inhibitors prime CAR T cells in CLL.Blood
Not labelled yetRapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry.Haematologica
Not labelled yetParaneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia.Haematologica
Not labelled yetIntercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation.Haematologica
Not labelled yetGlucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis.Haematologica
Not labelled yetEfficacy of continuous zanubrutinib monotherapy versus fixed-duration acalabrutinib plus venetoclax or venetoclax plus obinutuzumab in treatment-naïve chronic lymphocytic leukemia: a network meta-analysis.Leukemia & lymphoma
Not labelled yetHow Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence From the Targeted Therapy Era.Clinical lymphoma, myeloma & leukemia
Not labelled yetSocial vulnerability index associates with chronic lymphocytic leukemia survival rates in the Detroit tri-county area.Cancer research communications
Not labelled yetBorderline tuberculoid leprosy with type 1 reaction mimicking leukaemia cutis in a patient with chronic lymphocytic leukaemia on acalabrutinib.BMJ case reports
Not labelled yetOptimizing CLL treatment after covalent BTK inhibition.Clinical advances in hematology & oncology : H&O
Case reportZanubrutinib Combined With Venetoclax for the Treatment of Central Nervous System-Involved Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Rare Case Report.Cancer reports (Hoboken, N.J.)
Not labelled yetTerminal differentiation program of CD8 T cells guides immunotherapeutic options for CLL patients.Blood
Not labelled yetADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
Not labelled yetEffects of Dioscin on NLRP3 Inflammasome Expression and Apoptosis in Chronic Lymphocytic Leukemia Cells.Immunopharmacology and immunotoxicology
Not labelled yetOutcomes of Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors (BTKi): A Retrospective Study From a Tertiary Healthcare Center in North India.Cureus
Not labelled yetReal-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study.Leukemia research
Not labelled yetReal-World Treatment Patterns, Tolerability, and Outcomes Among Patients With CLL/SLL Treated With First-Line Ibrutinib, Acalabrutinib, or Zanubrutinib in the US Community Oncology Setting: A Retrospective Cohort Study.EJHaem
Not labelled yetDecision-Making on First-Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi-Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy.Hematological oncology
Not labelled yetThe evolving evidence ecosystem in chronic lymphocytic leukemia: from linear hierarchies to integrated synthesis.Expert review of hematology
Not labelled yetA thyroid nodule consistent with chronic lymphocytic leukemia.Endocrinology, diabetes & metabolism case reports
Not labelled yetAptamers in cancer research: Focus on leukemia.Chinese medical journal
Not labelled yetBeyond age: The prognostic impact of frailty on in-hospital outcomes in chronic lymphocytic leukemia.Journal of geriatric oncology
Not labelled yetExanthematous drug eruption with reactive T-cell atypia in a patient with accelerated chronic lymphocytic leukemia.International journal of women's dermatology
Not labelled yetQuantitative systems pharmacology modeling identifies synthetic lethality opportunities with DNA damage response inhibitors in ATM-deficient chronic lymphocytic leukemia - a computational simulation study.Journal of pharmacokinetics and pharmacodynamics
ReviewChronic lymphocytic leukemia: recent advances and emerging therapeutic strategies.Blood research
Not labelled yetPersonalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug design, development and therapy
Not labelled yetShortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.Cancer medicine
Not labelled yetComment on "Costs and consequences of cardiovascular toxicity due to Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia".Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
Case reportConcurrent treatment of chronic lymphocytic leukemia and acquired von Willebrand syndrome using a Bruton tyrosine kinase inhibitor: a case report.Blood transfusion = Trasfusione del sangue
Case reportLeukemia Cutis at the Diagnosis of Chronic Lymphocytic Leukemia: A Case Report.Cureus
Not labelled yetScalable Arrayed T-cell CRISPR Screening in Autologous Tumor Co-cultures to Prioritize Combination Partners for T-cell Engagers.Current protocols
Not labelled yetReal-World Treatment Patterns and Outcomes of Zanubrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at University of California Academic Health Centers: A Retrospective Cohort Study.Oncology and therapy
Not labelled yetMeasurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.Leukemia
Not labelled yetT cell-driven venetoclax resistance in chronic lymphocytic leukemia: in vivo preclinical activity of opaganib.Frontiers in immunology
Case reportCD23-negative atypical chronic lymphocytic leukemia with a novel three-way translocation t(4;10;13), unmutated: immunoglobulin heavy chain variable gene, and stereotyped subset #6 (case report).The Pan African medical journal
Not labelled yetTAILORing ibrutinib dose and plasma levels in the real-life patient with chronic lymphocytic leukemia.The Journal of pharmacology and experimental therapeutics
Not labelled yetCorrelation of Epstein-Barr virus (EBV) expressed miRNAs (BART4, BART7, and BHRF1) with chronic lymphocytic leukemia stages.Infectious agents and cancer
ReviewNavigating Measurable Residual Disease as a Surrogate Endpoint in Chronic Lymphocytic Leukemia.Hematological oncology
ReviewRichter Transformation of Chronic Lymphocytic Leukaemia: Biology, Diagnosis, and an Evolving Therapeutic Landscape.Biomedicines
Not labelled yetReal-world effectiveness and safety of fixed-duration frontline venetoclax-obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study.Leukemia research
Not labelled yetAssociation of Cbl-Interacting Protein CIN85 with Protein Phosphatase 2A (PP2A) Partly Confer Neoplastic Properties to Human Leukemia Cell Lines.Cells
Not labelled yetExpression of TCTP/HRF and MCL-1 in chronic lymphocytic leukemia: implications for disease pathogenesis.Molecular biology reports
Not labelled yetThe genomic and transcriptomic landscape of chronic lymphocytic leukaemia: Insights from an integrated analysis of 275 patients.British journal of haematology
Not labelled yetPTPN2/PTPN1 inhibition enhances ex vivo T- cell responses and potentiates mosunetuzumab activity in chronic lymphocytic leukemia.Frontiers in immunology
Case reportCollision of Malignant Melanoma and Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Case Report and Literature Review.Dermatopathology (Basel, Switzerland)
Not labelled yetTargeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia.American journal of cancer research
Not labelled yetPulmonary Involvement in Chronic Lymphocytic Leukemia: A Structured Diagnostic Approach to Diffuse Infiltrates-A Case Report.EJHaem
Not labelled yetConcordance between bone marrow and blood measurable residual disease after first-line novel agent treatment for chronic lymphocytic leukemia: a systematic review and meta-analysis.Leukemia
Not labelled yetUSP7 inhibits FOXO1 activity in chronic lymphocytic leukaemia cells enhancing cell survival.Molecular oncology
Not labelled yetIκBζ target genes in chronic lymphocytic leukemia.iScience
Not labelled yetPirtobrutinib for the Treatment of Therapy-Resistant Chronic Lymphatic Leukemia With CNS Localization.Case reports in hematology
Case reportProlonged Active SARS-CoV-2 Infection in a Patient With Chronic Lymphocytic Leukemia on Venetoclax.Cureus
Not labelled yetTP53 mutations and IGHV in naïve chronic lymphocytic leukemia: retrospective analysis of data from a Spanish collaborative network.International journal of hematology
Not labelled yetImmunoglobulin kinetics and infection patterns across venetoclax-based regimens in chronic lymphocytic leukemia.Leukemia & lymphoma
Not labelled yetSurvival Outcomes in Chronic Lymphocytic Leukemia During the Novel Agent Era: A Population-Based Analysis.Cancer medicine
Not labelled yetA Novel BCL2 Translocation and Concurrent Chromosome 13q14 Deletion in Chronic Lymphocytic Leukemia: A Case Report.EJHaem
Not labelled yetMRD-guided ibrutinib plus venetoclax improves quality of life in relapsed/refractory CLL: HOVON 141/VISION trial results.Blood advances
Case reportAn Atypical Presentation of Richter's Transformation in Chronic Lymphocytic Leukemia: Stroke-Like Onset With Multiorgan Involvement Including the Heart and Seminal Vesicles.Cureus
Not labelled yetCorrection: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.Leukemia
Not labelled yetClinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.Blood advances
Observational studyEfficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG).Advances in clinical and experimental medicine : official organ Wroclaw Medical University
ReviewStereotyped CLL-like immunoglobulin rearrangements in healthy repertoires: implications for leukemogenesis.Frontiers in immunology
Not labelled yetTreatment adherence in chronic lymphocytic leukaemia and chronic myeloid leukaemia: An integrative review.Enfermeria clinica
Not labelled yetCord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expression.Haematologica
Not labelled yetThe maturation of precision medicine into pragmatic, patient-centered care: A commentary on the 2026 EHA CLL Guidelines.HemaSphere
Not labelled yetComment on "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation".HemaSphere
Not labelled yetFrom Daffodils to Drug Leads: Amaryllidaceae Alkaloids Target Protein Translation in Chronic Lymphocytic Leukemia to Induce Selective Apoptosis.ACS pharmacology & translational science
Not labelled yetDefects in ribosomes and translational control in lymphoid leukemia and lymphoma.Seminars in hematology
Not labelled yetA Rare Case of Chronic Lymphocytic Leukemia and Chronic Myeloid Leukemia in an Elderly Patient: A Case Report.Clinical case reports
Case reportDiagnosis of acute myeloid leukaemia in a previously diagnosed case of chronic lymphocytic leukaemia in a dog.Australian veterinary journal
Case reportFalse-negative HHV-8 immunohistochemistry in Kaposi sarcoma: Clinicopathologic correlation leading to diagnosis of occult chronic lymphocytic leukemia.JAAD case reports
Not labelled yetAplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor-Case Report.EJHaem
Not labelled yetInfluence of gut microbiota on chronic lymphocytic leukemia development and aggressiveness.Gut microbes reports
Not labelled yet[Chronic lymphocytic leukemia presenting initially as purpura nephritis: a case report].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
ReviewBruton Tyrosine Kinase Inhibitor-Based Therapy Versus Rituximab-Containing Regimens for Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Cureus
Not labelled yetResponse to two comments on "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation" by S. Molica and A. Tedeschi: Beyond the binary choice.HemaSphere
Not labelled yetImmunomodulatory Receptor ILT3/LILRB4 Protects Human Leukemic B Cells From Ferroptosis In Vitro.European journal of immunology
Not labelled yetReal-world treatment patterns and outcomes in patients with chronic lymphocytic leukemia previously exposed to both covalent Bruton's tyrosine kinase inhibitor and B-cell lymphoma 2 inhibitor therapy.Haematologica
Not labelled yetPersistent SARS-CoV-2 RNA Positivity in a Chronic Lymphocytic Leukaemia Patient for 127 Days After Disease Onset: A Case Report.Respirology case reports
Not labelled yetTelomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.Blood
Not labelled yetSingle-cell sequencing reveals transcriptional and immunogenetic diversity in stereotyped chronic lymphocytic leukemia.Blood neoplasia
Not labelled yetEVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.Blood
Not labelled yetTLR9-dependent migration identifies different Chronic Lymphocytic Leukemia signaling states under BTK inhibition.Blood
Not labelled yetDiagnosis and Management of Chronic Lymphocytic Leukemia with TP53 Loss of Function in the Novel Agent Era.Blood
Not labelled yetExtranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors.Cancer medicine
Case reportChronic lymphocytic leukemia associated with genetic susceptibility and occupational glyphosate exposure: a case report.Frontiers in oncology
Not labelled yetFirst-line ibrutinib-venetoclax in chronic lymphocytic leukemia: GLOW 67-month results and grade 3/4 adverse event-free progression-free survival.Leukemia
Not labelled yetZNF292 mutations impair RNA and protein biosynthesis defining an adverse prognostic subset in early-stage chronic lymphocytic leukemia.Biomarker research
Not labelled yetPlasmablastic Richter Transformation of Chronic Lymphocytic Leukemia With Aberrant Epithelial Marker Expression Presenting as a Pleural Effusion: A Diagnostic Challenge.Case reports in pathology
Not labelled yetInhibition of ROR1 signaling with zilovertamab plus ibrutinib in chronic lymphocytic leukemia: safety, mechanistic insights, and an exploratory signal in del(17p) disease.Leukemia
Case reportFirst reported human Castellaniella defragrans bacteraemia: a case report.Swiss medical weekly
Not labelled yetRefractory Chronic Lymphocytic Leukemia Successfully Bridged to CAR T-Cell Therapy Using Splenic Radioembolization.Journal of vascular and interventional radiology : JVIR
Not labelled yetVenetoclax consolidation deepens response and enables measurable residual disease-guided finite therapy in BTK inhibitor-treated chronic lymphocytic leukemia.Leukemia & lymphoma
Case reportClinical improvement of pemphigus-like mucocutaneous disease in a patient with CLL following initiation of zanubrutinib: a case report.Frontiers in immunology
Not labelled yetClinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.Methods in molecular biology (Clifton, N.J.)
ReviewTargeting the Epigenetic-Immune Axis in Acute Myeloid Leukemia: Current Advances and Future Directions.Current oncology reports
Not labelled yetRenal risk differences between diffuse large B-cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: implications for supportive oncology care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ReviewCurrent management of central nervous system involvement in chronic lymphocytic leukemia/small lymphocytic lymphoma.International journal of hematology
ReviewZAP-70 as a prognostic laboratory biomarker in chronic lymphocytic leukemia: flow-cytometric assessment, clinical utility, and standardization challenges.Clinica chimica acta; international journal of clinical chemistry
ReviewLymph node models of chronic lymphocytic leukemia for translational evaluation of new drug candidates.Expert opinion on drug discovery
Not labelled yetTLR8 Stimulation Leads to Microenvironment Activation and Enhanced Antibody-Dependent Cellular Responses in CLL.International journal of molecular sciences
Not labelled yetGene expression analysis after BTK and PI3Kδ inhibitor treatment in chronic lymphocytic leukemia identifies cell-surface CXCR4 as a synergistic target for combinatorial therapy.HemaSphere
Not labelled yetCirculating Extracellular Vesicle Biomarkers in Chronic Lymphocytic Leukemia: A Preliminary Study on Their Diagnostic, Prognostic, and Predictive Relevance.Biomolecules
Not labelled yetHodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia.Blood cancer journal
Not labelled yetA prospective, multi-center, phase IV clinical study to assess the safety and clinical outcome of acalabrutinib in Indian adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed/refractory mantle cell lymphoma.Frontiers in oncology
Not labelled yetTranscriptomic and miRNA-Target Pathway Analysis of the DLK1-DIO3 Imprinted microRNA Cluster in Chronic Lymphocytic Leukemia.Diseases (Basel, Switzerland)
Not labelled yetIn-frame variants in TP53 gene identified in adult leukemia samples are predominantly deleterious: a study of the TP53 Network of Education and Research Initiative on CLL.The Journal of pathology
Not labelled yetAberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL.Leukemia
ReviewNon-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies.Oncology research
Not labelled yetEarly-onset CLL is characterized by enhanced microenvironment-driven metabolic fitness, increased proliferative bias, and accelerated disease progression.Frontiers in immunology
Not labelled yetProspective patient preference study for chronic lymphocytic leukemia (CLL) treatment attributes impacting patient shared decision-making.Expert review of anticancer therapy
Not labelled yetLenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia-Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups.British journal of haematology
Case reportEmergence of Two Rare Malignancies, Langerhans Cell Sarcoma and Myeloid Sarcoma, After Targeted Therapy for Chronic Lymphocytic Leukaemia: A Case Report.Cureus
Not labelled yetAcquired Amegakaryocytic Thrombocytopenia Presenting as Pancytopenia in a Patient With Chronic Lymphocytic Leukemia: A Case Report.Case reports in hematology
Case reportAcute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship.Journal of hematopathology
Not labelled yetInfiltrative Nephropathy in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma: A Systematic Review and Attribution Analysis.Journal of nephrology
Case reportExtragenital Mycoplasma hominis infection following obinutuzumab therapy in a patient with chronic lymphocytic leukemia.IDCases
ReviewProgress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.Frontiers in immunology
Not labelled yetA functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax.HemaSphere
Not labelled yetAutoimmune hemolytic anemia and chronic lymphocytic leukemia: crossing the borders between autoimmunity and malignancy.Haematologica